Table 2.
Anthropometric and metabolic characteristics of NAFLD study population by abnormal TG and non–HDL-C
| Variables | Elevated TG (n = 170) | Normal (n = 24) | P value | Elevated non-HDL-C (n = 113) | Normal (n = 83) | P value |
|---|---|---|---|---|---|---|
| Weight, kg | 91.1 (35.8) | 95.8 (49.2) | .58 | 92.8 (33.2) | 90.3 (42.9) | .64 |
| Height, cm | 158.0 (16.1) | 160.4 (15.4) | .51 | 159.5 (14.7) | 156.6 (17.6) | .22 |
| BMI | ||||||
| BMI, kg/m2 | 35.3 (9.2) | 36.4 (13.7) | .63 | 35.5 (8.6) | 35.4 (11.1) | .93 |
| BMI percentile | 98.7 (2.5) | 95.8 (10.9) | .0038 | 98.6 (2.8) | 98.0 (5.9) | .31 |
| SystoLic BP, mm Hg | 122.5 (14.1) | 124.9 (18.7) | .56 | 124.7 (14.1) | 120.3 (14.9) | .09 |
| DiastoLic BP, mm Hg | 66.9 (9.9) | 67.1 (11.1) | .94 | 67.8 (10.7) | 65.6 (8.9) | .23 |
| Liver enzymes, U/L | ||||||
| ALT | 90.5 (64.0) | 56.0 (35.8) | .01 | 94.0 (66.3) | 74.9 (54.3) | .03 |
| AST | 61.3 (45.4) | 44.7 (18.8) | .08 | 61.6 (43.5) | 55.8 (42.9) | .35 |
| GGT | 50.1 (39.9) | 30.2 (19.3) | .035 | 53.9 (43.4) | 38.4 (27.6) | .02 |
| InsuLin, mIU/L | 47.0 (41.9) | 34.1 (19.8) | .35 | 45.1 (39.4) | 45.3 (40.8) | .98 |
| HbA1c, % | 5.9 (1.6) | 6.0 (2.1) | .90 | 6.0 (1.6) | 5.9 (1.7) | .65 |
| TotaL choLesteroL, mg/dL | 173.6 (33.5) | 139.4 (21.1) | <.0001 | 191.0 (27.3) | 140.8 (16.6) | <.0001 |
| Non-HDL-C, mg/dL | 134.8 (32.3) | 92.8 (20.9) | <.0001 | 153.3 (25.9) | 99.2 (15.8) | <.0001 |
| HDL-C, mg/dL | 38.8 (9.1) | 46.6 (10.3) | .0001 | 38.4 (9.5) | 41.5 (9.5) | .03 |
| LDL-C, mg/dL | 104.9 (29.4) | 79.0 (21.2) | <.0001 | 119.9 (23.4) | 77.5 (17.3) | <.0001 |
| TrigLycerides, mg/dL | 201.7 (97.8) | 62.5 (17.5) | <.0001 | 220.5 (104.8) | 136.2 (77.0) | <.0001 |
NAFLD, nonalcoholic fatty liver disease; TG, triglyceride; non–HDL-C, non–high-density lipoprotein cholesterol; BMI, body mass index; BP, blood pressure; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma-glutamyl transferase; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.
Data are presented as mean (standard deviation).
Significance considered at P ≤ .05 and is in bold.